Compare VIR & MUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIR | MUX |
|---|---|---|
| Founded | 2016 | 1979 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2019 | 1994 |
| Metric | VIR | MUX |
|---|---|---|
| Price | $9.76 | $11.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | $23.38 | ★ $28.40 |
| AVG Volume (30 Days) | ★ 1.8M | 1.2M |
| Earning Date | 11-04-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 17.49 | N/A |
| EPS | N/A | ★ 0.10 |
| Revenue | $68,556,000.00 | ★ $197,553,000.00 |
| Revenue This Year | $305.75 | $11.31 |
| Revenue Next Year | N/A | $60.21 |
| P/E Ratio | ★ N/A | $120.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.32 | $11.99 |
| 52 Week High | $14.38 | $29.70 |
| Indicator | VIR | MUX |
|---|---|---|
| Relative Strength Index (RSI) | 39.70 | 30.82 |
| Support Level | $8.23 | N/A |
| Resistance Level | $10.32 | $20.62 |
| Average True Range (ATR) | 0.80 | 0.85 |
| MACD | -0.06 | -0.19 |
| Stochastic Oscillator | 1.39 | 4.00 |
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.